Israel | Imports and Exports | World | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" from Israel totalled $ 395 million in 2023. Sales of commodity group 3003 from Israel decreased by 72% in value terms compared to 2022. exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" decreased by $ 1.03 billion (cumulative exports of commodity group 3003 from Israel amounted $1.43 billion in 2022)
Exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" amounted to 0.659% of total exports from Israel (cumulative merchandise exports from Israel totalled $ 59 billion in 2023). The share of commodity group 3003 in total exports from Israel decreased by 1.31 p.p. compared to 2022 (it was 1.97% in 2022 and cumulative exports from Israel were equal to $ 72 billion).
Exports of commodity group 3003 amounted to 21% of total sales of group "" from Israel in 2023 (the value of exports of commodity group from Israel amounted to $1.8 billion in 2023). The share of exports of commodity group 3003 in sales of commodity group from Israel lowered by 23 p.p. compared to 2022 (it was 45% in 2022, and exports of commodity group from Israel were $3.17 billion).
Where does Israel export Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale?
Top export destinations of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" from Israel in 2023:
- United Kingdom with a share of 93% (369 million US$)
- USA with a share of 4.5% (17.8 million US$)
- Russia - 3.65 million US$
- Thailand - 2.44 million US$
- Italy - 1.17 million US$
- Germany - 251 thousand US$
- Korea - 224 thousand US$
- Georgia - 138 thousand US$
- Azerbaijan - 135 thousand US$
- South Africa - 76 thousand US$
Exports structure of 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale - from Israel in 2023 represented by the following main commodity groups:
- 98% (390 million US$): 300390 - Medicaments (excl. of 30.02/30.05/30.06) consisting of mixed/unmixed products for therapeutic/propnylactic uses, not put up in measured doses/forms/packagings for retail sale [see complete text #27]
- 0.985% (3.89 million US$): 300320 - Medicaments consisting of 2/more constituents, cont. other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for retail sale
- 0.074% (293 thousand US$): 300339 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics (excl. meds. cont. insulin), not put up in measured doses/forms/packagings for retail sale
- 0% (3 thousand US$): 300310 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for retail sale
The value of imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" to Israel totalled $ 20 million in 2023. Sales of commodity group 3003 to Israel went up by 25% compared to 2022: imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" went up by $ 4.27 million (the value of imports of commodity group 3003 to Israel was equal to $16.6 million in 2022)
Imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" accounted for 0.025% of total import flow to Israel (in 2023, total imports to Israel amounted to $ 83 billion). The share of commodity group 3003 in total imports to Israel increased by 0.009 p.p. compared to 2022 (it was 0.015% in 2022 and cumulative imports to Israel were equal to $ 107 billion).
Imports of commodity group 3003 reached 0.633% of total imports of group "" to Israel in 2023 (imports of commodity group to Israel totalled $3.3 billion in 2023). The share of purchases of commodity group 3003 in total imports of commodity group to Israel increased by 0.172 p.p. compared to 2022 (it was 0.46% in 2022, and imports of commodity group to Israel accounted for $3.61 billion).
Where does Israel import Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale from?
Top trading partners (import of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale") of Israel in 2023:
- USA with a share of 43% (9.04 million US$)
- Germany with a share of 15.2% (3.18 million US$)
- United Kingdom with a share of 10.8% (2.26 million US$)
- Italy with a share of 9.16% (1.91 million US$)
- Canada with a share of 5.89% (1.23 million US$)
- Bulgaria with a share of 3.71% (776 thousand US$)
- Denmark with a share of 3.16% (661 thousand US$)
- Switzerland with a share of 2.93% (613 thousand US$)
- India with a share of 2.7% (566 thousand US$)
- Belgium with a share of 1.65% (346 thousand US$)
Imports structure of 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale - to Israel in 2023 represented by the following main commodity groups:
- 76% (15.9 million US$): 300390 - Medicaments (excl. of 30.02/30.05/30.06) consisting of mixed/unmixed products for therapeutic/propnylactic uses, not put up in measured doses/forms/packagings for retail sale [see complete text #27]
- 23% (4.93 million US$): 300320 - Medicaments consisting of 2/more constituents, cont. other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for retail sale
- 0.014% (3 thousand US$): 300310 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for retail sale
